SELECTED ASPECTS OF ALLO- AND XENOGRAFT MODEL APPLICATIONS FOR DEVELOPING NOVEL ANTI-CANCER VACCINES AND ONCOLYTIC VIRUSES
To date, cancer diseases are one of the leading causes of mortality and morbidity in the world. Recent advances in understanding the molecular genetic mechanisms of oncogenesis and anti-cancer immune responses open new opportunities for the development of novel effective therapeutic strategies again...
Enregistré dans:
Auteurs principaux: | T. S. Nepomnyashchikh, E. V. Gavrilova, R. A. Maksyutov |
---|---|
Format: | article |
Langue: | RU |
Publié: |
SPb RAACI
2019
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/c797440fe6244527ad58c8df1f2d8ed5 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Oncolytic Viruses: Newest Frontier for Cancer Immunotherapy
par: Masmudur M. Rahman, et autres
Publié: (2021) -
Oncolytic Virotherapy
Publié: (2016) -
SHORT OVERVIEW OF CLINICAL TRIALS WITH CURRENT IMMUNOTHERAPEUTIC TOOLS FOR CANCER TREATMENT
par: T. S. Nepomnyashchikh, et autres
Publié: (2017) -
The combination therapy of oncolytic HSV-1 armed with anti-PD-1 antibody and IL-12 enhances anti-tumor efficacy
par: Xin Xie, et autres
Publié: (2022) -
Oncolytic adenovirus inhibits malignant ascites of advanced ovarian cancer by reprogramming the ascitic immune microenvironment
par: Gang Shi, et autres
Publié: (2021)